1-4 of 4
Salem Ajib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interventional Antibiotic Treatment Replacing Antibiotic Prophylaxis during Allogeneic Hematopoietic Stem Cell Transplantation Is Safe and Feasible: A Single-Center Analysis

Rosa Toenges, Fabian Lang, Rakhshinda Ghaffar, Vera Schlipfenbacher, Julia Riemann, Salem Ajib, Khouloud Kouidri, Anjali Cremer, Weber Bodo, Thu Nguyen, Antje Knoch, Janne Vehreschild, Hubert Serve, Gesine Bug
Journal: Blood
Blood (2022) 140 (Supplement 1): 10478–10479.
https://doi.org/10.1182/blood-2022-163303
Published: 2022
Journal Articles

Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study

Esther Schuler, MD, Eva-Maria Wagner-Drouet, MD, Salem Ajib, MD, Gesine Bug, Martina Crysandt, MD, Sabine Dressler, MD, Andreas Hausmann, MD, Daniela Heidenreich, MD, Klaus Hirschbühl, MD, Matthias Hoepting, MD, Edgar Jost, MD, Jennifer Kaivers, MD, Stefan A Klein, MD, Lambros Kordelas, MD, Oliver Kriege, MD, Lutz Peter Mueller, MD, Christina Rautenberg, MD, Judith Schaffrath, MD, Christoph Schmid, MD, Daniel Wolff, MD, Martin Bornhaeuser, MD, Thomas Schroeder, MD, Guido Kobbe, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4563.
https://doi.org/10.1182/blood-2019-125087
Published: 2019
Journal Articles

Impact of Donor Chimerism-Guided Immunomodulation after Allogeneic Stem Cell Transplant on the Outcome of Patients with AML and MDS

Juliane Steinmann, Sarah Lindner, MD, Zuzana Jedlickova, MD, Salem Ajib, MD, Saskia C. Gueller, MD, Tobias Berg, MD, Julia Riemann, MD, Fabian Lang, MD, Rosa Toenges, MD, Hans Martin, MD, Michael Kramer, M.Sc., Johannes Schetelig, MD MSc, Hubert Serve, MD, Christian Thiede, MD, Gesine Bug
Journal: Blood
Blood (2018) 132 (Supplement 1): 2133.
https://doi.org/10.1182/blood-2018-99-116088
Published: 2018
Journal Articles

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Salem Ajib, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Livius Penter, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, Michael Luebbert, MD, Ralph M. Waesch, MD PhD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Robert Negrin, MD, Mats L Brune, Alexandros Spyridonidis, Annette Schmitt-Graeff, MD, Walter van der Velden, MD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MDPhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Joerg Halter, MD, Gerard Socie, Dietrich Beelen, MD, Christian Peschel, MD, Andreas Neubauer, MD, Juergen Finke, MD, Justus Duyster, MD PhD, Nikolas von Bubnoff, MD
Journal: Blood
Blood (2015) 126 (23): 858.
https://doi.org/10.1182/blood.V126.23.858.858
Published: 2015